A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

Document Details

Document Type
Pub Defense Publication
Publication Date
Jan 01, 2016
Source ID
10.1016/j.nicl.2016.05.017

Entities

People

  • Chadwick P. Ward
  • Christopher G. Schwarz
  • Clifford Jack
  • Dennis W. Dickson
  • Heather J. Wiste
  • Jeffrey L Gunter
  • Joseph E. Parisi
  • Kejal Kantarci
  • Matthew L Senjem
  • Melissa E. Murray
  • Michael W. Weiner
  • Prashanthi Vemuri
  • Ronald C. Petersen
  • Scott A. Przybelski
  • Stephen D. Weigand

Organizations

  • AbbVie
  • Alzheimer's Association
  • Alzheimer's Disease Neuroimaging Initiative
  • Alzheimer's Drug Discovery Foundation
  • BioClinica
  • Biogen
  • Bristol-Myers Squibb
  • Canadian Institutes of Health Research
  • Chiron Corporation
  • Eisai (South Korea)
  • Eli Lilly and Company
  • GE HealthCare
  • Hoffmann-La Roche
  • Innogenetics
  • Johnson & Johnson Pharmaceutical Research and Development
  • Lundbeck
  • Merck & Co.
  • Meso Scale Diagnostics (United States)
  • National Institute of Biomedical Imaging and Bioengineering
  • National Institute on Aging
  • National Institutes of Health
  • Pfizer
  • Roche (United States)
  • Takeda Pharmaceutical Company
  • United States Department of Defense